- Home
- Equities - Stocks - Shares
- Company Press Releases
- Correction: Nordhealth AS - Q3/2022 Results Presentation
Correction: Nordhealth AS - Q3/2022 results presentation
29 Nov 2022 08:15 CET
Issuer
Nordhealth AS
Reference is made to Nordhealth AS - Q3/2022 results presentation, published on
the 25 of November 2022.
The correction mainly refers to graphs on pages 16 and 18. Please find attached
a corrected version of the presentation.
For further information, please contact:
Charles MacBain, CEO
charles.macbain@nordhealth.com
+44 75 3903 2200
About Nordhealth
Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS
company on a mission to redefine digital healthcare. We build software that
empower veterinary and therapy professionals to provide the best possible care
experiences to their patients. Our products serve more than 50,000 veterinary
and therapy professionals across 10,000 clinics and hospitals located in over 30
countries.
Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the
Nordic region and a growing presence internationally, with more than 400
employees working either remotely or from offices (collaboration hubs). Visit
the company's website at nordhealth.com (http://www.nordhealth.com).
More information:
Access the news on Oslo Bors NewsWeb site
Source
Nordhealth AS
Provider
Oslo Børs Newspoint
Company Name
NORDHEALTH AS A-AKSJER
ISIN
NO0011002651
Symbol
NORDH
Market
Euronext Growth